Schröder R, Kumar R, Williams B T. "一种的合成方法" [P]. US Patent, US 11521778 B2, 2022-04-27.
Johansson L, Björnsson E, Sørensen M. "Method for the Synthesis of (2R,3R,4S,5R)-2-(6-((3-Fluorophenyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol" [P]. European Patent, EP 3241243 A1, 2018-11-12.
发明人杨光,林芳,孙丽萍. "A Process for Preparing High-Purity (2R,3R,4S,5R)-2-(6-((3-Fluorophenyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol" [P]. 中国发明专利, 专利号 CN 109969331 B, 授权公告日 2016-02-01.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2012, 1955, (11), 3426-3447.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2018, 1055, (7), 7555-7582.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of (2R,3R,4S,5R)-2-(6-((3-Fluorophenyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2021, 1732, (2), 4016-4046.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2020, 2318, (11), 5821-5836.